Skip to main content

Human Bikunin Antibody

R&D Systems, part of Bio-Techne | Catalog # AF7744

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
AF7744
AF7744-SP

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Sheep IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Bikunin
Ala206-Asn352
Accession # P02760

Specificity

Detects human Bikunin in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Sheep

Isotype

IgG

Scientific Data Images for Human Bikunin Antibody

Detection of Human Bikunin antibody by Western Blot.

Detection of Human Bikunin by Western Blot.

Western blot shows human urine. PVDF membrane was probed with 0.5 µg/mL of Sheep Anti-Human Bikunin Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7744) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). A specific band was detected for Bikunin at approximately 35-45 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Applications for Human Bikunin Antibody

Application
Recommended Usage

Western Blot

0.5 µg/mL
Sample: Human urine

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Sterile PBS to a final concentration of 0.2 mg/mL. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Bikunin

Bikunin (also known as I alphaI light chain, EDC1, HI30 and Trypstatin) is a secreted, 35-45 kDa proteoglycan member of the kunin family of serine protease inhibitors. It is expressed by hepatocytes, amniotic epithelium and mesothelial cells. Bikunin possesses both sulfated and nonsulfated GAG sequences. The nonsulfated sequences are known to form ester linkages with two 80 kDa "heavy" chains in the hepatocyte Golgi, forming 180-200 kDa I alphaI. This molecule participates in the formation of hyaluronan-containing ECM. In addition, one of the H chains of I alphaI can be displaced by TSG6, creating an antiplasmin complex. Human bikunin is generated through cleavage of a precursor molecule termed AMBP. This AMBP should not be confused with AMBP-1, a 120-140 kDa adrenomedullin-binding protein that is also known as Complement Factor H. The AMBP precursor contains a 19 aa signal sequence, an N-terminal 183 aa A1M protein (aa 20-203), and the C-terminal serine protease inhibitor bikunin (aa 206-352). Bikunin possesses one GAG attachment site at Ser215, two Kunitz inhibitor domains (aa 231-281 and 287-337) and one utilized N-linked glycosylation site at Asn250. Although cleavage of AMBP in the Golgi may result in release of free bikunin, the 60-65 kDa AMBP precursor can also be released intact. Over aa 206-352, human bikunin shares 77% aa sequence identity with mouse bikunin.

Alternate Names

A1M;AMBP;EDC1;HCP;HI30;IATIL;ITI;ITIL;ITILC;Protein AMBP;UTI

Entrez Gene IDs

259 (Human)

Gene Symbol

AMBP

UniProt

Additional Bikunin Products

Product Documents for Human Bikunin Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Bikunin Antibody

For research use only

Loading...
Loading...
Loading...
Loading...